If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
ROCHESTER, N.Y., Aug. 3 (HSMN NewsFeed) — Bausch & Lomb Surgical has announced the US launch of its new Akreos® AO Micro Incision Lens (Model MI60L). In the US, the company refers to this lens as the Akreos® MICS(TM) lens. This unique spherical …
Devices, Ophthalmology
Bausch & Lomb, Akreos AO, Akreos MICS, Intraocular Lens
Posts on ‘August 3rd, 2009’
Bausch and Lomb Surgical Launches the Akreos(R) AO Micro Incision IOL
Breast Cancer Radiation Guidelines Called Positive Step
ASTRO Document Stresses Importance of Minimizing Radiation to Healthy Tissue PHOENIX–(HSMN NewsFeed)–The new pharmaceutical consensus statement on accelerated partial breast irradiation is an important step toward defining patient selection criteria and high…
Devices, Oncology
ASTRO , partial breast irradiation, breast cancer, radiotherapy, brachytherapy
Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and Fifty MG
MORRISTOWN, N.J., Aug. 3 (HSMN NewsFeed) — Watson Pharmaceuticals, Inc. (NYSE: WPI ), a big specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United States Food and…
Biopharmaceuticals, Generics, FDA
Watson Pharmaceuticals, Watson Laboratories, metoprolol, AstraZeneca, Toprol XL
Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ
ALLEGAN, Mich., Aug. 3 (HSMN NewsFeed) — Perrigo Company (Nasdaq: PRGO; TASE) today announced that its partner Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ; previously Barr Laboratories Inc.) has received final approval from the U.S. Food and Drug…
Biopharmaceuticals, Generics, FDA
Perrigo, Teva Pharma, triamcinolone acetonide, NASACORT
NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
EMERYVILLE, Calif., Aug. THREE (HSMN NewsFeed) — NovaBay Pharmaceuticals, Inc. (NYSE-Amex: NBY) today announced that Roy J. Wu has joined the company as senior vice president for business development. Wu brings to NovaBay more than Thirty years of highly succes…
Biopharmaceuticals, Personnel
NovaBay Pharmaceuticals
